Spravato and Ketamine
COMING JANUARY 2020. JOIN OUR WAIT LIST NOW.

Athena Consulting believes in utilizing all evidence and research based treatment options to better serve our clients, including newer medications and modalities of treatment. That is why we have taken the steps necessary to become one of the first certified Spravato treatment centers in the greater Nashville area.

On March 5, 2019, the U.S. Food and Drug Administration (FDA) approved Spravato™ (esketamine) nasal spray. Spravato™ is a prescription medicine, used along with an antidepressant taken by mouth, for treatment-resistant depression (TRD) in adults. Spravato™ is the latest advancement in over a decade approved by the FDA to treat TRD.

What is Spravato™ ?

Spravato™ is brand name for esketamine produced by Janssen Pharmaceutical Company of Johnson & Johnson. Spravato™ is only available in a nasal spray form, and only approved by the FDA for treating patients suffering from treatment-resistant depression (TRD).

Is Spravato™ right for me?

Spravato™ is FDA approved exclusively for adults suffering from Treatment Resistant Depression (TRD).  Patients suffering from depression are typically considered treat-resistant if they have not sufficiently responded to at least two different antidepressants of adequate dose and duration in the current depressive episode. To determine if Spravato™ is right for you, contact our team at Athena Consulting to discuss your specific situation and treatment options.

Where do I get Spravato™?

Although Spravato™ esketamine is administered as a nasal spray, people will not be permitted to purchase it for home use. To guard against abuse, patients will need to use Spravato under medical supervision at a clinic or doctor’s office that has been certified by the maker of Spravato™ as an authorized provider. Athena Consulting is a certified authorized provider of Spravato™.

Do I qualify for treatment with Spravato™?

Spravato™ is not for everyone.  Spravato™ is only approved for adults suffering from Treatment Resistant Depression (TRD).  To determine if you qualify, your doctor will work with you on the qualification process. Contact us to discuss your specific situation, review the qualification requirements, and learn about treatment options.

Does my insurance cover Spravato™?

Spravato™ was approved by the FDA in March 2019.  Most insurance providers are now offering coverage for qualified patients.  As first step, contact Athena Consulting and our team will help you understand your insurance coverage and other possible affordability options.

Where do I go to get Spravato™ treatments?

Spravato™ treatments are administered under the direct supervision of a medical doctor and the supporting medical staff at Athena Consulting. Spravato™ is not available for use outside the medical clinic.

What are the potential side effects and risks of Spravato™?

Contact us to learn more about Spravato™.  For additional information about Spravato™ from Janssen Pharmaceuticals, Inc., the maker of Spravato™, visit www.spravato.com

How can I get more information about Spravato™?

Call Athena Consulting at 615-320-1155 to learn more about Spravato™, or fill out the appointment form below.